denosumab-bbdz Jubbonti
Selected indexed studies
- Denosumab-bbdz: A Review of the Interchangeable Biosimilar for the Treatment of Osteoporosis. (Ann Pharmacother, 2026) [PMID:40509651]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.